Animal Diagnostics Market Size & Growth Forecast 2027–2036, By Segments (Animal, Technology, Product, End-use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Animal Diagnostics Market size was over USD 5.63 Billion in 2026 and is likely to grow at 9.65% CAGR between 2027 and 2036, crossing USD 14.14 Billion by 2036. The industry revenue for 2027 is estimated at USD 6.09 Billion.
Get more details on this report
Request Free Sample ReportAnimal Diagnostics Market Intelligence Snapshot
Regional Market Dynamics
- North America held 43.35% share in 2026, supported by advanced veterinary infrastructure, high pet ownership, preventive healthcare awareness, and strong adoption of diagnostic technologies.
- Asia Pacific is expanding through improving veterinary infrastructure, rising companion animal ownership, growing livestock production, disease prevention needs, and wider point-of-care testing adoption.
Segment Momentum
- Companion animals accounted for 74.88% of the market in 2026 and remain the fastest-growing segment, driven by rising pet ownership, higher spending on veterinary care, and growing demand for preventive diagnostics and routine health monitoring.
- Molecular diagnostics is the fastest-growing technology segment due to increasing demand for accurate pathogen detection, rapid disease identification, genetic analysis, and advances in nucleic acid testing methods.
Market Expansion Drivers
- Rising companion animal adoption increasing demand for advanced veterinary diagnostic services
- Growing zoonotic and foodborne disease burden driving preventive animal health diagnostics
- Expansion of pet insurance ecosystems improving affordability and diagnostic test penetration
Leading Market Participants
- Key players in the animal diagnostics market include IDEXX Laboratories, Inc. (United States), Zoetis Inc. (United States), Boehringer Ingelheim International GmbH (Germany), bioMérieux SA (France), Thermo Fisher Scientific Inc. (United States), Neogen Corporation (United States), QIAGEN N.V. (Germany), Virbac S.A. (France), Heska Corporation (United States), Randox Laboratories Ltd. (United Kingdom)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 5.63 Billion
- 2027 Estimated Market Size: USD 6.09 Billion
- Projected Market Size: USD 14.14 Billion by 2036
- Growth Forecast: 9.65% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Companion Animals (Animal) | Clinical Biochemistry (Technology) | Consumables (Product) | Veterinary Clinics (End-use) | Bacteriology (Application)
- Emerging Opportunity Segment: Companion Animals (Animal) | Molecular Diagnostics (Technology) | Consumables (Product) | Veterinary Hospitals (End-use) | Pathology (Application)
Market Growth Drivers and Industry Trends
Rising companion animal adoption increasing demand for advanced veterinary diagnostic services
Increasing ownership of companion animals is changing expectations around veterinary care, and the animal diagnostics market growth is supported by rising demand for accurate and timely diagnostic services. Pet owners are showing greater interest in preventive healthcare, early disease detection, and advanced monitoring solutions that improve animal wellbeing. Veterinary clinics are responding by adopting diagnostic technologies that enable faster identification of health conditions and support improved treatment decisions.
Growing zoonotic and foodborne disease burden driving preventive animal health diagnostics
The need to monitor animal health risks is increasing as veterinary systems focus on controlling diseases that can affect livestock, food safety, and public health, which will propel the animal diagnostics market growth. Diagnostic testing plays an important role in early disease identification, surveillance programs, and preventive health management across animal populations. Expanding awareness of disease transmission risks is encouraging broader utilization of testing solutions in veterinary and agricultural settings.
Expansion of pet insurance ecosystems improving affordability and diagnostic test penetration
Growing availability of financial support mechanisms for veterinary care is improving access to advanced healthcare services, helping the animal diagnostics market growth through increased diagnostic test adoption among pet owners. Insurance coverage can reduce cost barriers associated with routine screening, laboratory testing, and specialized veterinary procedures. As more owners seek comprehensive healthcare options for animals, veterinary providers are expanding the use of diagnostic tools within regular care pathways.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising companion animal adoption increasing demand for advanced veterinary diagnostic services | 2% | Moderate | North America, Europe | High | Near Term |
| Growing zoonotic and foodborne disease burden driving preventive animal health diagnostics | 1.9% | High | Asia Pacific, Africa | High | Near Term |
| Expansion of pet insurance ecosystems improving affordability and diagnostic test penetration | 1.6% | Moderate | North America, Europe | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the animal diagnostics market at 43.35% in 2026, supported by advanced veterinary healthcare infrastructure, high pet ownership, and growing awareness of preventive animal healthcare. The increasing humanization of pets is encouraging owners to seek timely diagnostic services and comprehensive disease management, while livestock producers are placing greater emphasis on monitoring animal health to protect productivity and food safety. Strong adoption of laboratory testing, imaging, and point-of-care diagnostic technologies is further strengthening the regional market. In addition, established veterinary networks and continued innovation in animal healthcare are supporting broader use of advanced diagnostic solutions.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to experience the fastest growth, driven by improving veterinary infrastructure, rising companion animal ownership, and increasing awareness of animal disease prevention. Growing livestock production and the need to manage infectious diseases are also creating demand for accessible and reliable diagnostic technologies. Healthcare modernization across emerging economies is improving the availability of veterinary laboratories and specialized services, while rising disposable incomes are encouraging greater spending on companion animal care. Increasing adoption of rapid and point-of-care testing is further enabling earlier diagnosis and treatment across both livestock and companion animal segments.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Veterinary Precision TestingThe U.S. animal diagnostics market is driven by advanced testing solutions for companion animals and livestock, including molecular diagnostics and rapid point-of-care kits. Veterinary networks in the U.S. increasingly adopt integrated diagnostic platforms to support early disease detection and treatment monitoring.
Germany 🇩🇪
Regulatory-Grade DiagnosticsGermany emphasizes high-quality, validated animal diagnostic systems aligned with strict veterinary and food safety regulations. Diagnostic providers in Germany focus on laboratory-grade testing solutions for livestock health monitoring and zoonotic disease control.
Japan 🇯🇵
Companion Animal Care ExpansionJapan’s animal diagnostics market is strongly influenced by growing demand for advanced diagnostics in companion animal healthcare. Veterinary clinics in Japan increasingly invest in imaging, blood analysis, and genetic testing tools tailored for small animal care.
South Korea 🇰🇷
Digital Veterinary IntegrationSouth Korea is adopting digitally integrated animal diagnostics platforms that connect veterinary clinics with centralized data systems. In South Korea, demand is rising for automated diagnostic tools that improve efficiency in both companion and livestock health management.
France 🇫🇷
Livestock Health MonitoringFrance prioritizes animal diagnostics for livestock health management and disease surveillance in agricultural systems. Veterinary services in France focus on scalable diagnostic testing solutions that support food safety compliance and herd health optimization.
Italy 🇮🇹
Preventive Veterinary ScreeningItaly emphasizes preventive screening in animal diagnostics, particularly for livestock and equine health management. Veterinary providers in Italy increasingly rely on routine diagnostic testing to support early intervention and improve long-term animal health outcomes.
Segment Leadership and Growth Trends
Animal Diagnostics Market Share (%), Animal, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportAnimal Segment Analysis: Companion Animals (Largest & Fastest-Growing Segment)
The animal diagnostics market was dominated by the companion animals segment, which held 74.88% of the market share in 2026 and is also anticipated to be the fastest-growing segment. Rising pet ownership, increasing expenditure on animal healthcare, and growing awareness of preventive veterinary care continue to drive demand for advanced diagnostic testing. The expanding availability of specialized veterinary services, coupled with greater emphasis on early disease detection and routine health monitoring, is strengthening the adoption of diagnostic solutions for companion animals.
Technology Segment Analysis: Clinical Biochemistry (Largest Segment) vs Molecular Diagnostics (Fastest-Growing Segment)
The clinical biochemistry segment accounted for the largest share of 38.12% in 2026. Its leadership is supported by the widespread use of biochemical testing for routine assessment of organ function, metabolic disorders, and overall animal health. Veterinary clinics and diagnostic laboratories continue to rely on clinical biochemistry because of its established clinical utility, broad diagnostic applications, and ability to deliver timely information for treatment planning.
In the animal diagnostics market, the molecular diagnostics segment is expected to witness the fastest growth during the forecast period. Increasing demand for highly accurate pathogen detection, rapid disease identification, and genetic analysis is driving broader adoption of molecular diagnostic technologies. Advances in nucleic acid testing methods and growing focus on controlling infectious diseases among both companion and farm animals are expected to further accelerate the expansion of this segment.
Product Segment Analysis: Consumables (Largest & Fastest-Growing Segment)
The animal diagnostics market was led by the consumables segment in 2026, and it is also expected to remain the fastest-growing product category. The recurring need for reagents, assay kits, test cartridges, and other laboratory supplies across routine veterinary diagnostics creates sustained demand from veterinary hospitals, clinics, and diagnostic laboratories. Continuous growth in diagnostic testing volumes and ongoing innovation in veterinary diagnostic assays are expected to reinforce the segment's leading market position.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Animal | Farm Animals, Companion Animals | Companion Animals | Companion Animals |
| Technology | Immunodiagnostics, Clinical Biochemistry, Hematology, Molecular Diagnostics, Urinalysis, Others | Clinical Biochemistry | Molecular Diagnostics |
| Product | Instruments, Consumables | Consumables | Consumables |
| End-use | Veterinary Clinics, Veterinary Hospitals, Others | Veterinary Clinics | Veterinary Hospitals |
| Application | Bacteriology, Parasitology, Pathology, Others | Bacteriology | Pathology |
Competitive Landscape and Market Positioning
Leading companies in the animal diagnostics market:
- IDEXX Laboratories, Inc. (United States)
- Zoetis, Inc. (United States)
- Boehringer Ingelheim International GmbH (Germany)
- bioMérieux SA (France)
- Thermo Fisher Scientific, Inc. (United States)
- Neogen Corporation (United States)
- QIAGEN N.V. (Germany)
- Virbac S.A. (France)
- Heska Corporation (United States)
- Randox Laboratories Ltd. (United Kingdom)
The animal diagnostics market is evolving toward comprehensive diagnostic ecosystems that support faster clinical decisions across companion animal care, livestock health management, and disease surveillance. Suppliers are strengthening their position by integrating laboratory testing with point-of-care technologies, digital reporting platforms, and workflow tools that improve diagnostic accessibility for veterinary professionals. Competitive emphasis is also shifting toward assays capable of detecting multiple conditions with greater efficiency while maintaining reliable performance in varied clinical settings. Growing expectations for preventive healthcare, biosecurity, and herd management are encouraging continuous investment in diagnostic innovation that aligns with routine veterinary practice as well as large-scale monitoring programs.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| MI:RNA | Oct-25 | MI:RNA secured funding to accelerate the development of a proprietary, AI-based diagnostic tool optimized for the early detection of canine osteoarthritis. The capital injection supports the commercialization of artificial intelligence applications within veterinary diagnostics, addressing an underserved customer segment in companion animal care. |
| Zoetis | Jun-25 | Zoetis launched AI Masses, an artificial intelligence-driven cytologic capability integrated into its Vetscan Imagyst platform. The launch represents a significant technological innovation for point-of-care veterinary diagnostics, enabling rapid, in-clinic detection of potentially cancerous cells to optimize testing workflows and accuracy. |
| Breath Diagnostics Startup | Jun-25 | A Tennessee-based startup advanced the development of a novel breath-analysis diagnostic device targeted at early detection of bovine respiratory disease. By adapting technology originally engineered for human use during the COVID-19 pandemic, the development introduces material technological innovation to the livestock diagnostic segment. |
| IDEXX Laboratories | Jun-24 | IDEXX Laboratories introduced the Catalyst Pancreatic Lipase Test, a point-of-care diagnostic solution designed for rapid canine and feline pancreatitis testing. Delivering quantitative results in under 10 minutes, the launch provides significant functional differentiation to enhance immediate veterinary diagnostic capabilities during patient visits. |
| FaunaTech | Feb-24 | FaunaTech expanded its smartphone-based diagnostics platform to facilitate rapid milk testing and livestock health assessments at the farm level. This commercial footprint expansion improves agricultural distribution reach and operational access to immediate bovine health data, driving down point-of-need diagnostic barriers. |
| bioMérieux | Apr-23 | bioMérieux entered into a strategic partnership agreement with Oxford Nanopore to co-develop innovative infectious disease diagnostics. This technology integration aims to deliver advanced in vitro diagnostics, expanding ecosystem capabilities and accelerating the commercialization of novel infectious disease detection solutions. |
| Zoetis Inc. | Sep-22 | Zoetis Inc. acquired NewMetrica, a Scotland-based pioneer in digital instruments. The acquisition enhances Zoetis's companion animal portfolio by integrating advanced digital instruments into its offerings, directly strengthening its competitive positioning and consolidating its footprint within the veterinary diagnostics market. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Animal Diagnostics Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Animal Diagnostics Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of animal diagnostics?
How is the animal diagnostics industry size expected to evolve during the forecast period?
What factors are increasing demand for animal diagnostic services?
How is pet insurance supporting growth in the animal diagnostics market?
Why do companion animals lead the animal diagnostics market?
Which technology segment is expected to grow the fastest in the animal diagnostics market?
Why does North America lead the animal diagnostics market?
What is driving rapid growth in Asia Pacific’s animal diagnostics market?
Which companies dominate the animal diagnostics landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization